1. Search Result

Search Result

Targets Recommended: GPR55 CRISPR/Cas9

Results for "2436473-55-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-132193

    RET Cancer
    RET-IN-4 is a potent, selective and orally active RET inhibitor with IC50s of 1.29 nM, 1.97 nM, and 0.99 nM for RET (WT), RET (V804M), and RET (M918T), respectively. RET-IN-4 exhibits better kinases selectivity against JAK2 (IC50 of 4.4 nM) and FLT3 (IC50 of 30.8 nM). RET-IN-4 has anticancer effects.